Central inhibition of AT1-R, TNF-α synthesis or microglial activation significantly attenuated either HFD- or leptin-induced upregulation of RAS activity, inflammation in the LT and PVN, and HFD or leptin sensitization of ANG II-induced hypertension. The gene discussed is LEP; the disease is Hypertension.